Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Atosiban. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR known ✓ | P30559 | 6/20 | 0.71 |
| ▸ | AVPR1A | P37288 | 3/20 | 0.68 |
| ▸ | AVPR1B | P47901 | 3/20 | 0.68 |
| ▸ | AVPR2 | P30518 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Atosiban SCHEMBL29522709 | 1.00 | OXTR (0.71) | OXTRAVPR1AAVPR1BAVPR2 | |
| Atosiban SCHEMBL19712221 | 1.00 | OXTR (0.71) | OXTRAVPR1AAVPR1BAVPR2 | |
| Atosiban SCHEMBL1648581 | 1.00 | OXTR (0.71) | OXTRAVPR1AAVPR1BAVPR2 | |
| Atosiban SCHEMBL4410202 | 0.98 | OXTR (0.69) | OXTRAVPR1AAVPR1BAVPR2 | |
| Atosiban SCHEMBL3138542 | 0.98 | OXTR (0.69) | OXTRAVPR1AAVPR1BAVPR2 | |
| Atosiban SCHEMBL4414282 | 0.97 | OXTR (0.67) | OXTRAVPR1AAVPR1BAVPR2 | |
| SCHEMBL21255736 | 0.95 | OXTR (0.72) | OXTRAVPR1AAVPR1BAVPR2 | |
| SCHEMBL26813594 | 0.90 | OXTR (0.58) | OXTRAVPR1AAVPR1BAVPR2 | |
| SCHEMBL15511860 | 0.89 | OXTR (0.81) | OXTRAVPR1AAVPR1BAVPR2 | |
| Atosiban SCHEMBL13723569 | 0.88 | OXTR (0.56) | OXTRAVPR1AAVPR1BAVPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2779 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746850-A1 | EXTENDED RELEASE DRUG-LOADED MICROPARTICLES | Ferring BV (NL) | 2026-05-27 | — | — | EP | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| CN-121586705-A | Small molecule prostaglandin F receptor antagonists | 辉凌公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4688804-A1 | METHODS OF MANUFACTURING PEPTIDE SALTS | Ferring BV (NL) | 2026-02-11 | — | — | EP | claimed |
| US-12533321-B2 | Polypeptide formulations for oral delivery | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2026-01-27 | — | — | US | claimed |
| US-12466851-B2 | Manufacture of disulfide bonded peptides | BACHEM HOLDING AG (CH) | 2025-11-11 | — | — | US | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | claimed |
| WO-2025227105-A1 | CLEAVABLE LINKERS WITH TUNABLE HALF-LIVES | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2025-10-30 | — | — | WO | claimed |
| EP-4631514-A1 | ORAL POLYPEPTIDE COMPOSITION AND USE THEREOF | Hefei Tianhui Biotech Co., Ltd. (CN) | 2025-10-15 | — | — | EP | claimed |
| EP-4601623-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | Bhami's Research Laboratory, Pvt. Ltd. (IN) | 2025-08-20 | — | — | EP | claimed |
| US-5763405-A | VASOPRESSIN, OXYTOCIN WITH ENTERIC COATING | FERRING B.V. (NL) | 1998-06-09 | — | — | US | claimed |
| WO-1998009632-A1 | METHODS AND COMPOSITIONS FOR TREATING PRETERM LABOR | MERCK & CO., INC. (US) | 1998-03-12 | — | — | WO | claimed |
| CN-1143911-A | Stabilized composition for oral administration of peptides | FERRING AB (NL) | 1997-02-26 | — | — | CN | claimed |
| EP-0752877-A1 | STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | FERRING B.V. (NL) | 1997-01-15 | — | — | EP | claimed |
| EP-0710122-A1 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | FERRING B.V. (NL) | 1996-05-08 | — | — | EP | claimed |
| US-5482931-A | STORAGE STABILITY; BUFFER, PRESERVATIVE OR DISINFECTANT, AND OSMOTIC PRESSURE-CONTROLLING AGENT | FERRING AB (SE) | 1996-01-09 | — | — | US | claimed |
| EP-0689452-A1 | COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | FJELLESTAD-PAULSEN, Anne (FR) | 1996-01-03 | — | — | EP | claimed |
| WO-1995025534-A1 | STABILIZED COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | FJELLESTAD PAULSEN ANNE (FR) | 1995-09-28 | — | — | WO | claimed |
| WO-1995001185-A1 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | FERRING B.V. (NL) | 1995-01-12 | — | — | WO | claimed |
| WO-1994021286-A1 | COMPOSITION FOR ORAL ADMINISTRATION OF PEPTIDES | FJELLESTAD PAULSEN ANNE (FR) | 1994-09-29 | — | — | WO | claimed |